Literature DB >> 11810277

Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease.

R Abraham1, A Myers, F Wavrant-DeVrieze, M L Hamshere, H V Thomas, H Marshall, D Compton, G Spurlock, D Turic, B Hoogendoorn, J M Kwon, R C Petersen, E Tangalos, J Norton, J C Morris, R Bullock, D Liolitsa, S Lovestone, J Hardy, A Goate, M O'Donovan, J Williams, M J Owen, L Jones.   

Abstract

Insulin-degrading enzyme (IDE; insulysin; EC 3.4.24.56) is a 110-kDa neutral metallopeptidase that can degrade a number of peptides including beta-amyloid. The gene encoding IDE is located on chromosome 10 close to a region of linkage for late-onset Alzheimer's disease (LOAD) and thus is a functional and positional candidate for this disorder. We analysed all of the coding exons, untranslated regions and 1000 bp of 5'-flanking sequence of IDE by using denaturing high-performance liquid chromatography and sequencing. We detected eight single nucleotide polymorphisms (SNPs), three in the 5' flanking sequence and five in the coding sequence, of which three were found at lower than 5% frequency. None of them changed the amino acid sequence. We genotyped the five SNPs with allele frequencies of more than 5% in 133 Caucasian LOAD cases and 135 controls collected in the UK and 95 cases and 117 controls collected at the Mayo Clinic, Rochester, USA. Two of the SNPs were analysed in a further independent case-control sample (Washington University, St. Louis: 86 cases, 94 controls). No significant association was found with any individual SNP in any of the samples or with any haplotypes. Analysis of the marker D10S583, which maps 36 kb upstream of IDE, also failed to show association in 134 cases and 111 matched controls from the UK ( P=0.63). Strong linkage disequilibrium was detected between the five SNPs that spanned the whole of the 120-kb genomic region of IDE and one major and a number of minor haplotypes were detected in the populations studied. We conclude that IDE does not make a substantial contribution to the aetiology of LOAD and therefore cannot account for the linkage between LOAD and 10q.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11810277     DOI: 10.1007/s00439-001-0614-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease.

Authors:  Denise Harold; Timothy Peirce; Valentina Moskvina; Amanda Myers; Susan Jones; Paul Hollingworth; Pamela Moore; Simon Lovestone; John Powell; Catherine Foy; Nicola Archer; Sarah Walter; Amanda Edmonson; Stephen McIlroy; David Craig; Peter A Passmore; Alison Goate; John Hardy; Michael O'Donovan; Julie Williams; Malcolm Liddell; Michael J Owen; Lesley Jones
Journal:  Hum Genet       Date:  2003-05-21       Impact factor: 4.132

Review 2.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

3.  New Alzheimer's disease locus on chromosome 8.

Authors:  V Giedraitis; M Hedlund; L Skoglund; E Blom; S Ingvast; R Brundin; L Lannfelt; A Glaser
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

4.  A novel method, the Variant Impact On Linkage Effect Test (VIOLET), leads to improved identification of causal variants in linkage regions.

Authors:  Lisa J Martin; Lili Ding; Xue Zhang; Ahmed H Kissebah; Michael Olivier; D Woodrow Benson
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

5.  Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.

Authors:  J H Lee; R Mayeux; D Mayo; J Mo; V Santana; J Williamson; A Flaquer; A Ciappa; H Rondon; P Estevez; R Lantigua; T Kawarai; A Toulina; M Medrano; M Torres; Y Stern; B Tycko; E Rogaeva; P St George-Hyslop; J A Knowles
Journal:  Mol Psychiatry       Date:  2004-11       Impact factor: 15.992

6.  HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.

Authors:  Sarah E Lloyd; Martin Rossor; Nick Fox; Simon Mead; John Collinge
Journal:  BMC Med Genet       Date:  2009-09-15       Impact factor: 2.103

7.  IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults.

Authors:  G Peggy McFall; Sandra A Wiebe; David Vergote; David Westaway; Jack Jhamandas; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2013-04-16       Impact factor: 4.673

8.  Neprilysin Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese.

Authors:  Hui-Zhen Wang; Rui Bi; Deng-Feng Zhang; Guo-Dong Li; Xiao-Hong Ma; Yiru Fang; Tao Li; Chen Zhang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2015-09-11       Impact factor: 5.590

Review 9.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

10.  Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Olivia Belbin; Fanggeng Zou; Mariet Allen; Nilufer Ertekin-Taner; Morad Ansari; Samantha L Wilcox; Mariah R Kashino; Li Ma; Linda H Younkin; Samuel G Younkin; Curtis S Younkin; Toros A Dincman; Melissa E Howard; Chanley C Howell; Chloe M Stanton; Christopher M Watson; Michael Crump; Veronique Vitart; Caroline Hayward; Nicholas D Hastie; Igor Rudan; Harry Campbell; Ozren Polasek; Kristelle Brown; Peter Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Patrick G Kehoe; David M Mann; A David Smith; Helen Beaumont; Donald Warden; Clive Holmes; Reinhard Heun; Heike Kölsch; Noor Kalsheker; V Shane Pankratz; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Alan F Wright; Steven G Younkin; Kevin Morgan
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.